Literature DB >> 11979044

Development of the capacity of peripheral blood mononuclear cells to produce IL-4, IL-5 and IFN-gamma upon stimulation with house dust mite in children with atopic dermatitis.

Mitsuaki Kimura1, Akiko Yamaide, Satoru Tsuruta, Ikuo Okafuji, Takami Yoshida.   

Abstract

BACKGROUND: Imbalances of IL-4 and IFN-gamma production are widely known to increase IgE synthesis in allergic individuals, and IL-5 is known to play a critical role in the pathogenesis of various allergic diseases. However, little is known about how Th cells specific to house dust mite (HDM) develop the capacity to produce these cytokines in children with atopic dermatitis (AD).
OBJECTIVE: This study aims to clarify when HDM-specific Th cells develop the capacity to produce IL-4, IL-5 and IFN-gamma in children with AD.
METHODS: The production of IL-4, IL-5 and IFN-gamma by peripheral blood mononuclear cells (PBMCs) upon stimulation with HDM was measured in 91 children with AD and 37 control subjects. The changes in the cytokine production with age were analyzed transectionally and longitudinally.
RESULTS: IL-4 production by HDM-stimulated PBMCs in children with AD was already increased before age 1. Thereafter, it continuously rose until reaching a near-maximum level at age 2. Growth-related changes in the production of IL-5 resembled those in the production of IL-4 and peaked at age 1. The production of these cytokines was very low in control subjects up to age 2 and then gradually increased, albeit never above the levels measured in AD children. The production of IFN-gamma in children with AD reached a near-maximum level during the first year of life and diminished after age 3. Although IFN-gamma production in controls was lower than that in AD children during infancy, it continuously rose even after age 3 and surpassed the levels measured in AD children. The level of serum HDM-specific IgE antibody began to increase after age 1 following the rise of IL-4 production. Essentially the same relationship among IL-4, IFN-gamma and IgE synthesis was seen in a longitudinal study of 6 AD infants, in whom HDM-specific IgE was initially negative but later turned positive.
CONCLUSIONS: These findings suggest that the capacity of HDM-specific Th cells to produce IL-4, IL-5 and IFN-gamma develops and effectively matures during the first 3 years of life in children with AD. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979044     DOI: 10.1159/000053863

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Relationship between maternal and child cytokine responses to allergen and phytohaemagglutinin 2 years after delivery.

Authors:  A-K Larsson; C Nilsson; A Höglind; E Sverremark-Ekström; G Lilja; M Troye-Blomberg
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  The impact of 17β-estradiol and progesterone therapy on peripheral blood mononuclear cells of asthmatic patients.

Authors:  Leila Nejatbakhsh Samimi; Morteza Fallahpour; Majid Khoshmirsafa; Seyed Ali Javad Moosavi; Paria Bayati; Rasoul Baharlou; Reza Falak
Journal:  Mol Biol Rep       Date:  2020-12-14       Impact factor: 2.316

3.  Intracellular production of IL-2, IL-4, IFN-gamma, and TNF-alpha by peripheral blood CD3+ and CD4+ T cells in children with atopic dermatitis.

Authors:  Edyta Machura; Bogdan Mazur; Jarosław Kwiecień; Krystyna Karczewska
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

4.  Impaired Toll-like receptor 2-mediated Th1 and Th17/22 cytokines secretion in human peripheral blood mononuclear cells from patients with atopic dermatitis.

Authors:  Yangyang Yu; Yarui Zhang; Jie Zhang; Xia Dou; Hong Yang; Yong Shao; Kepeng Wang; Bo Yu; Wei Zhang; Hang Yung Alaster Lau
Journal:  J Transl Med       Date:  2015-12-18       Impact factor: 5.531

5.  Ragweed subpollen particles of respirable size activate human dendritic cells.

Authors:  Kitti Pazmandi; Brahma V Kumar; Krisztina Szabo; Istvan Boldogh; Arpad Szoor; Gyorgy Vereb; Agota Veres; Arpad Lanyi; Eva Rajnavolgyi; Attila Bacsi
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.